HK1231508A1 - 含有血小板含量的組合物 - Google Patents

含有血小板含量的組合物

Info

Publication number
HK1231508A1
HK1231508A1 HK17105152.4A HK17105152A HK1231508A1 HK 1231508 A1 HK1231508 A1 HK 1231508A1 HK 17105152 A HK17105152 A HK 17105152A HK 1231508 A1 HK1231508 A1 HK 1231508A1
Authority
HK
Hong Kong
Prior art keywords
compositions containing
containing platelet
platelet contents
contents
compositions
Prior art date
Application number
HK17105152.4A
Other languages
English (en)
Inventor
Allan B Dietz
Greg W Butler
Michael P Gustafson
Original Assignee
Mayo Found Medical Education & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42040115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1231508(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mayo Found Medical Education & Res filed Critical Mayo Found Medical Education & Res
Publication of HK1231508A1 publication Critical patent/HK1231508A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK17105152.4A 2008-09-16 2017-05-22 含有血小板含量的組合物 HK1231508A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9749008P 2008-09-16 2008-09-16

Publications (1)

Publication Number Publication Date
HK1231508A1 true HK1231508A1 (zh) 2017-12-22

Family

ID=42040115

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105152.4A HK1231508A1 (zh) 2008-09-16 2017-05-22 含有血小板含量的組合物

Country Status (6)

Country Link
US (4) US20110171731A1 (zh)
EP (3) EP2334785B2 (zh)
DK (2) DK2334785T4 (zh)
ES (2) ES2588383T5 (zh)
HK (1) HK1231508A1 (zh)
WO (1) WO2010033605A2 (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121979A1 (en) * 2003-12-29 2013-05-16 Allan Mishra Method of treating cancer using platelet compositions
EP2334785B2 (en) 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions containing platelet contents
EP2389942B1 (en) * 2010-05-25 2013-01-23 GwoWei Technology Co., Ltd. Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
US20120231542A1 (en) * 2011-03-11 2012-09-13 General Biotechnology, Llc Biologically Active Human Umbilical Cord Blood Cell Extract Compounds and Methods
AU2012275562B2 (en) * 2011-06-27 2016-10-20 Children's Healthcare Of Atlanta, Inc. Compositions, uses, and preparation of platelet lysates
AU2012279995C1 (en) 2011-07-06 2019-10-24 Cell Therapy Limited Progenitor cells of mesodermal lineage
US20140335195A1 (en) 2011-11-23 2014-11-13 Cell Therapy Limited Platelet lysate gel
CN104080907A (zh) * 2011-11-30 2014-10-01 日本国立癌症研究中心 诱导恶性干细胞
US9682104B2 (en) 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
CA2922205C (en) 2013-08-27 2021-08-17 Cook General Biotechnology Llc Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same
EP3038551A4 (en) * 2013-08-27 2017-03-08 Mayo Foundation for Medical Education and Research Cross-linked platelet material
EP4328299A3 (en) * 2014-05-16 2024-05-29 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
WO2016014854A1 (en) 2014-07-23 2016-01-28 Cerus Corporation Methods for preparing platelet products
JP2018507916A (ja) * 2015-03-11 2018-03-22 ベフファル アタ エクソソーム送達技術
CA2987872A1 (en) 2015-05-29 2016-12-08 Amit Patel Particulate lyophilized platelet lysate compositions
FR3036707B1 (fr) 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
RU2648162C2 (ru) * 2016-04-21 2018-03-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В.Ломоносова" (МГУ) Способ получения ростовой добавки на основе лизата тромбоцитов из тромбоцитарной массы доноров к среде для наращивания клеточной массы стволовых, прогениторных, дифференцированных и опухолевых клеток
FR3077824B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
FR3077823B1 (fr) * 2018-02-15 2022-01-14 Maco Pharma Sa Procede de preparation d'un lysat plaquettaire irradie
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
CN116926001A (zh) * 2022-04-06 2023-10-24 上海我武干细胞科技有限公司 血清替代物及其制备方法与应用
CN114836381B (zh) * 2022-05-22 2023-03-28 北京赛尔再生医学生物科技有限公司 诱导间充质干细胞定向分化为神经细胞的方法及其培养基
CN115125191B (zh) * 2022-08-22 2023-10-13 浙江绿蔻生物技术有限公司 成纤维细胞转化培养基及其应用、成纤维细胞的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185160A (en) * 1984-06-21 1993-02-09 Prp, Inc. Platelet membrane microvesicles
SE8801537D0 (sv) * 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
US5756686A (en) * 1988-12-20 1998-05-26 Ludwig Institute For Cancer Research Peptides derived from endothelial cell growth factor
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
AU7988594A (en) 1993-12-08 1995-06-27 Universite De Montreal Process for the preparation of serum and platelet growth factors extract
US5834418A (en) * 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
US20020164322A1 (en) * 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
AU2002226426A1 (en) * 2002-01-09 2003-07-24 Alberto Gorrochategui Barrueta Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
WO2005065419A2 (en) 2003-12-29 2005-07-21 Am Biosolutions Method of culturing cells
US7678780B2 (en) * 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
US20060014266A1 (en) * 2004-06-10 2006-01-19 Cytokinetics, Inc. Purification of Arp2/3 complex and compositions containing purified Arp2/3 complex
US7335508B2 (en) * 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
SE528214C2 (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
US20090305401A1 (en) * 2006-09-18 2009-12-10 Dirk Strunk Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
WO2008110570A1 (en) 2007-03-13 2008-09-18 Medizinische Universität Graz Method to study proliferation of endothelial progenitor cells and the potential influence of compounds on their proliferation behaviour
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
EP2100954A1 (en) * 2008-03-10 2009-09-16 Assistance Publique - Hopitaux de Paris Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
WO2009144718A1 (en) * 2008-05-28 2009-12-03 Ramot At Tel Aviv University Ltd. Mesenchymal stem cells for the treatment of cns diseases
IT1392897B1 (it) * 2008-07-18 2012-04-02 Fond Ircss Ca' Granda - Ospedale Maggiore Policlinico Frazione piastrinica derivante da sangue placentare
JP2011529706A (ja) 2008-08-04 2011-12-15 アローキュア インコーポレイテッド 間充織間質細胞集団、ならびにそれを単離および使用する方法
EP2334785B2 (en) 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions containing platelet contents
US20120269779A1 (en) * 2009-10-30 2012-10-25 Allocure, Inc. Mesenchymal stromal cell populations and methods of using same
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
US20140335195A1 (en) 2011-11-23 2014-11-13 Cell Therapy Limited Platelet lysate gel
US9682104B2 (en) 2012-01-26 2017-06-20 Jadi Cell Llc Lyophilized platelet lysates
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
EP4328299A3 (en) 2014-05-16 2024-05-29 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
AU2016227607B2 (en) * 2015-03-04 2021-09-30 Mesoblast International Sarl Cell culture method for mesenchymal stem cells
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire

Also Published As

Publication number Publication date
EP2334785A2 (en) 2011-06-22
US20210154234A1 (en) 2021-05-27
US20190209617A1 (en) 2019-07-11
ES2588383T3 (es) 2016-11-02
EP2334785A4 (en) 2013-01-16
EP3095856A1 (en) 2016-11-23
WO2010033605A3 (en) 2010-07-22
US20110171731A1 (en) 2011-07-14
ES2588383T5 (es) 2020-04-22
EP2334785B1 (en) 2016-05-25
EP2334785B2 (en) 2019-08-14
EP3584310B1 (en) 2024-04-17
US20160082047A1 (en) 2016-03-24
DK2334785T3 (en) 2016-08-22
EP3095856B1 (en) 2019-08-14
ES2755551T3 (es) 2020-06-05
US10166258B2 (en) 2019-01-01
WO2010033605A2 (en) 2010-03-25
US10925901B2 (en) 2021-02-23
EP3584310A1 (en) 2019-12-25
DK3095856T3 (da) 2019-10-21
DK2334785T4 (da) 2019-11-18

Similar Documents

Publication Publication Date Title
HK1231508A1 (zh) 含有血小板含量的組合物
HK1159958A1 (zh) 含有非極性化合物的組合物
PT2796129E (pt) Composição contendo palmitoiletanolamida ultramicronizada
EP2356037A4 (en) CONTAINER
HK1154801A1 (en) Liquid composition comprising cisplatin-coordinating compound
HK1146479A1 (en) Packaging container
HK1154794A1 (en) Liquid oral composition
EP2216257A4 (en) CONTAINER FOR CONNECTIONS
EP2249641A4 (en) NOVEL COMPOSITIONS CONTAINING XANTHOHUMOL / CYCLODEXTRIN COMPLEXES
ZA201101413B (en) Sealed container
AP00230S1 (en) Container
HK1222096A1 (zh) 含有安石榴苷的營養組合物
HUE044237T2 (hu) Kortexolon-17-alfa-propionátot tartalmazó gyógyszerészeti kompozíciók
HK1160087A1 (en) Packing container
GB0800353D0 (en) Container
AU324472S (en) Container
IL225199A0 (en) Assembly to preserve the function of blood platelets
HU0700755D0 (en) Pharmaceutical compositions containing capsaicionid
GB0707739D0 (en) Packaging container
AU320378S (en) Container
AU320377S (en) Container
AU320376S (en) Container
GB0800188D0 (en) Container
AU320679S (en) Container
AU320539S (en) Container